[{"address1": "2215 Yukon Street", "city": "Vancouver", "state": "BC", "zip": "V5Y 0A1", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 586, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 48, "title": "CEO, President & Chairperson", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 714939, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 674555, "exercisedValue": 0, "unexercisedValue": 25365500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 38, "title": "COO & Director", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 650587, "exercisedValue": 1409524, "unexercisedValue": 5575004}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 53, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 667690, "exercisedValue": 0, "unexercisedValue": 7349760}, {"maxAge": 1, "name": "Marcie  Thiessen CPA, CGA", "title": "Senior Director of Finance & Accounting", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ester  Falconer Ph.D.", "age": 48, "title": "Chief Technology Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Kathleen  Reid B.A.", "title": "Head of Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Aubuchon B.A., M.B.A.", "age": 53, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 684813, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.52, "open": 2.52, "dayLow": 2.425, "dayHigh": 2.57, "regularMarketPreviousClose": 2.52, "regularMarketOpen": 2.52, "regularMarketDayLow": 2.425, "regularMarketDayHigh": 2.57, "beta": 0.367, "forwardPE": -3.283784, "volume": 2401881, "regularMarketVolume": 2401881, "averageVolume": 1831340, "averageVolume10days": 2269350, "averageDailyVolume10Day": 2269350, "bid": 2.42, "ask": 2.45, "bidSize": 1000, "askSize": 1000, "marketCap": 716038336, "fiftyTwoWeekLow": 2.4, "fiftyTwoWeekHigh": 6.055, "priceToSalesTrailing12Months": 21.662683, "fiftyDayAverage": 2.8415, "twoHundredDayAverage": 4.154225, "currency": "USD", "enterpriseValue": 144255136, "floatShares": 189396271, "sharesOutstanding": 294665984, "sharesShort": 18168144, "sharesShortPriorMonth": 17765588, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0617, "heldPercentInsiders": 0.28053, "heldPercentInstitutions": 0.41493, "shortRatio": 14.07, "shortPercentOfFloat": 0.0801, "impliedSharesOutstanding": 294665984, "bookValue": 3.77, "priceToBook": 0.64456236, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -153300000, "trailingEps": -0.53, "forwardEps": -0.74, "pegRatio": -0.42, "enterpriseToRevenue": 4.364, "enterpriseToEbitda": -0.672, "52WeekChange": -0.5467626, "SandP52WeekChange": 0.24014747, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "ABCL", "underlyingSymbol": "ABCL", "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "firstTradeDateEpochUtc": 1607697000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "3bee7a8c-17d1-3746-82e5-1968755076f0", "messageBoardId": "finmb_280568380", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.43, "targetHighPrice": 28.0, "targetLowPrice": 5.0, "targetMeanPrice": 15.43, "targetMedianPrice": 14.0, "recommendationMean": 1.9, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 670355968, "totalCashPerShare": 2.275, "ebitda": -214655008, "totalDebt": 72054000, "quickRatio": 10.487, "currentRatio": 10.963, "totalRevenue": 33054000, "debtToEquity": 6.486, "revenuePerShare": 0.113, "returnOnAssets": -0.11412, "returnOnEquity": -0.13297, "freeCashflow": -133388496, "operatingCashflow": -91391000, "revenueGrowth": -0.272, "operatingMargins": -12.76171, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]